Efficacy and Tolerability of Treatment With Lanthanum Carbonate in Patients With End Stage Renal Disease Receiving Dialysis

• Status: Completed
• Trial end date: 2006-01-12
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to assess phosphate reduction and control in patients with End Stage Renal Disease treated with lanthanum carbonate

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Shire

Criteria

Inclusion Criteria:

• Males and females of childbearing potential agree to take adequate precautions to prevent contraception

• Patients diagnosed with ESRD must have been receiving a stable dialysis regimen for chronic renal failure for the 2 consecutive months prior to enrollment in the study

• Patient requires treatment for hyperphosphataemia

Exclusion Criteria:

• Pregnant or lactating women

• Patients who continue to require treatment with compounds containing calcium, aluminum or magnesium

• Patients with clinically significant uncontrolled concurrent illness, a life-threatening malignancy or current multiple myeloma

• Patients who are HIV+

• Patients with any significant gastrointestinal surgery or disorders